Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases
- PMID: 11385458
- DOI: 10.1038/89289
Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases
Abstract
Apoptotic bodies can be used to target delivery of DNA-expressed immunogens into professional antigen-presenting cells (APCs). Here we show that antigen-laden apoptotic bodies created by vectors co-expressing influenza virus hemagglutinin (HA) or nucleoprotein (NP) genes and mutant caspase genes markedly increased T-cell responses. Both CD8 and CD4 T-cell responses were affected. The adjuvant activity was restricted to partially inactivated caspases that allowed immunogen expression before the generation of apoptotic bodies. Active-site mutants of murine caspase 2 and an autocatalytic chimera of murine caspase 2 prodomain and human caspase 3 induced apoptosis that did not interfere with immunogen expression. The adjuvant activity also enhanced B-cell responses, but to a lesser extent than T-cell responses. The large increases in T-cell responses represent one of the strongest effects to date of a DNA adjuvant on cellular immunity.
Comment in
-
Vaccines to die for.Nat Biotechnol. 2001 Jun;19(6):527-8. doi: 10.1038/89255. Nat Biotechnol. 2001. PMID: 11385447 Free PMC article. No abstract available.
Similar articles
-
Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun.Gene Ther. 2002 Jun;9(12):828-31. doi: 10.1038/sj.gt.3301696. Gene Ther. 2002. PMID: 12040466
-
Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.Antiviral Res. 2009 Mar;81(3):253-60. doi: 10.1016/j.antiviral.2008.12.009. Epub 2009 Jan 9. Antiviral Res. 2009. PMID: 19135483
-
Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.Cancer Gene Ther. 2004 Jun;11(6):397-407. doi: 10.1038/sj.cgt.7700711. Cancer Gene Ther. 2004. PMID: 15044962
-
Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.J Gene Med. 2004 Apr;6(4):445-54. doi: 10.1002/jgm.529. J Gene Med. 2004. PMID: 15079819
-
Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.Immunol Lett. 2009 Jan 29;122(1):58-67. doi: 10.1016/j.imlet.2008.12.006. Epub 2009 Jan 9. Immunol Lett. 2009. PMID: 19135479
Cited by
-
Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B.Infect Immun. 2005 Sep;73(9):5666-74. doi: 10.1128/IAI.73.9.5666-5674.2005. Infect Immun. 2005. PMID: 16113284 Free PMC article.
-
Modulation of plasmid DNA vaccine antigen clearance by caspase 12 RNA interference potentiates vaccination.Clin Vaccine Immunol. 2011 Apr;18(4):533-8. doi: 10.1128/CVI.00390-10. Epub 2011 Feb 16. Clin Vaccine Immunol. 2011. PMID: 21325489 Free PMC article.
-
Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.J Virol. 2010 Sep;84(17):8926-36. doi: 10.1128/JVI.00787-10. Epub 2010 Jun 10. J Virol. 2010. PMID: 20538851 Free PMC article.
-
Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines.Virol J. 2011 Jan 24;8:36. doi: 10.1186/1743-422X-8-36. Virol J. 2011. PMID: 21261958 Free PMC article.
-
DNA vaccines for HIV: challenges and opportunities.Springer Semin Immunopathol. 2006 Nov;28(3):267-79. doi: 10.1007/s00281-006-0046-z. Epub 2006 Oct 10. Springer Semin Immunopathol. 2006. PMID: 17031649 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous